Boston hit by charges, but Edwards grows across the board
This article was originally published in Clinica
Executive Summary
Second-quarter sales of Fort Worth, Texas-headquartered Alcon's ophthalmic surgical products increased faster than its pharmaceutical and consumer eyecare products. The growth in its surgical business was driven by strong sales of its premium, advanced technology intraocular lenses, in particular the AcrySof Toric and AcrySof ReSTOR Aspheric lenses. Sales of cataract and vitrectomy products, which went up 16% from the same period last year, also contributed to the growth. Alcon's laser vision correction franchise saw a three-fold increase in revenue, thanks to its acquisition of German refractive laser system developer Wavelight in November 2007.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.